Tags: Drug.

Veliparib (ABT-888) is a potential anti-cancer drug acting as a PARP inhibitor. It kills cancer cells by blocking a protein called PARP thereby preventing the repair of DNA or genetic damage in cancer cells and possibly making them more susceptible to anticancer treatments. Veliparib may make whole brain radiation treatment work more effectively against brain metastases from NSCLC.It inhibits both PARP1 and PARP2.

Veliparib_skeletal.svg
ATC prefix
none
DrugBank
DB07232
FDA UNII code
01O4K0631N
IUPAC name
2-((R)-2-Methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide
PubChem
11960529

Loading...

This page contains content from the copyrighted Wikipedia article "Veliparib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.